Companies /Healthcare

Merck & Co Inc

NYSE: MRK Drug Manufacturers - General
$152.02
▲ $2.52 (+1.69%) today
Markets open · 12:42pm ET

MRK Coverage

Page 69
6:27am ET
Investing

DJIA Component Earnings Trifecta (DD, MRK, UTX)

So far we have three DJIA components with earnings out.  DuPont (NYSE: DD), Merck & Co. (NYSE: MRK), United Technologies (NYSE: UTX) have all posted earnings.  So far there are no train…

Douglas A. McIntyre
5:46am ET
Investing

Short Interest In Banks Plunges

The short interest in most large banks fell very sharply for the period ending May 29, an indication that traders believe that TARP repayments and ongoing strong earnings mean the fate of American…

Douglas A. McIntyre
3:00am ET
Investing

Media Digest 6/4/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

Reuters:   GM and Chrysler said closing dealers was essential to their restructuring. Reuters:   The Justice Department is probing big tech employee recruiting. Reuters:   Medical bills underlay 60% of American bankruptcies.

Douglas A. McIntyre
8:46pm ET
Investing

Ten Women Who Should Be Big Company CEOs

Twelve of the Fortune 500 CEOs are women. Just twelve. Over the next year, that number is likely to go up considerably because of a confluence of economic and financial factors that…

Douglas A. McIntyre
6:23am ET
Investing

Merck (MRK): All Bad News

Merck released earnings, and cut its forecasts. No wonder. Its Q1 numbers were atrocious. Revenue  for the first quarter of 2009 was $5.4 billion, a decrease of 8%compared to the first quarter of…

MRK
Douglas A. McIntyre